A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506922-35-00

Acronym

TAS2940-101

Enrollment

Registered

2023-10-18

Start date

2022-01-24

Completion date

2025-03-24

Last updated

2024-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locally Advanced or Metastatic Solid Tumors with EGFR and/or HER2 Aberrations

None listed

Sex/Gender

All

Age

18 Years to No maximum

France

None listed

Source: EU CTIS · Data processed: Feb 4, 2026